Works matching IS 10834389 AND DT 2021 AND VI 26 AND IP 5

Results: 17

Favorable outcomes of rescue second‐ or third‐line culture‐based Helicobacter pylori eradication treatment in areas of high antimicrobial resistance.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12844
By:
- Lee, Jung Won;
- Kim, Nayoung;
- Nam, Ryoung Hee;
- Jang, Jae Young;
- Choi, Yonghoon;
- Lee, Dong Ho
Publication type:
Article
Dietary multivalent anti‐Helicobacter pylori immunoglobulin Y significantly increase the H. pylori eradication and improve the clinical symptoms in patients.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12843
By:
- Guo, Rong;
- Wu, Shan;
- Guan, Li;
- Xie, Yongmei;
- Yang, Xifei;
- Li, Zaixin;
- Zhang, Zhi
Publication type:
Article
Activation of Aquaporin 5 by carcinogenic Helicobacter pylori infection promotes epithelial‐mesenchymal transition via the MEK/ERK pathway.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12842
By:
- Li, Nianshuang;
- Xu, Xinbo;
- Yang, Hui;
- Wang, Huan;
- Ouyang, Yaobin;
- Zhou, Yanan;
- Peng, Chao;
- Yuan, Zhenxiang;
- He, Cong;
- Zeng, Chunyan;
- Hong, Junbo
Publication type:
Article
Application of molecular techniques in Helicobacter pylori detection: limitations and improvements.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12841
By:
- Gong, Lan;
- El‐Omar, Emad M
Publication type:
Article
Tetracycline‐levofloxacin versus amoxicillin‐levofloxacin quadruple therapies in the second‐line treatment of Helicobacter pylori infection.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12840
By:
- Hsu, Ping‐I;
- Tsay, Feng‐Woei;
- Kao, John Y.;
- Peng, Nan‐Jing;
- Chen, Yan‐Hua;
- Tang, Sheng‐Yeh;
- Kuo, Chao‐Hung;
- Kao, Sung‐Shuo;
- Wang, Huay‐Min;
- Wu, I‐Ting;
- Shie, Chang‐Bih;
- Chuah, Seng‐Kee;
- Wu, Deng‐Chyang
Publication type:
Article
Doxycycline and minocycline in Helicobacter pylori treatment: A systematic review and meta‐analysis.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12839
By:
- Zhao, Jixiang;
- Zou, Yunzhi;
- Li, Ke;
- Huang, Xin;
- Niu, Changping;
- Wang, Zikang;
- Zhao, Shuyang;
- Zhang, Yizhen;
- Song, Conghua;
- Xie, Yong
Publication type:
Article
Effect of Helicobacter pylori eradication on hyperplastic gastric polyps: A systematic review and meta‐analysis.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12838
By:
- Ouyang, Yaobin;
- Zhang, Wenjing;
- Huang, Yancheng;
- Wang, Yao;
- Shao, Qing;
- Wu, Xidong;
- Lu, Nonghua;
- Xie, Chuan
Publication type:
Article
Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost‐effectiveness analysis.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12837
By:
- Kowada, Akiko;
- Asaka, Masahiro
Publication type:
Article
Association between bacteria other than Helicobacter pylori and the risk of gastric cancer.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12836
By:
- Gunathilake, Madhawa;
- Lee, Jeonghee;
- Choi, Il Ju;
- Kim, Young‐Il;
- Kim, Jeongseon
Publication type:
Article
Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12835
By:
- Ouyang, Yaobin;
- Zhu, Zhihao;
- Huang, Li;
- Zeng, Chuanfei;
- Zhang, Lin;
- Wu, William KK;
- Lu, Nonghua;
- Xie, Chuan
Publication type:
Article
cagA+ Helicobacter pylori infection and N‐nitrosodimethylamine and cholangiocarcinoma.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12834
By:
- Mungmunpuntipantip, Rujittika;
- Wiwanitkit, Viroj
Publication type:
Article
10‐Day and 14‐day high‐dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12833
By:
- Zou, Pei‐Ying;
- Hu, Jie;
- Zhao, Jing‐Tao;
- Zhao, Zhe;
- Mei, Hao;
- Yang, Jing;
- Zhu, Yang‐Jie;
- Zhang, Yi;
- Lan, Chun‐Hui
Publication type:
Article
Application of WeChat platform in the management of patients infected with Helicobacter pylori.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12832
By:
- Ma, Huan;
- Zhao, Xin‐hua;
- Zhang, Li‐li;
- Wu, Li‐meng
Publication type:
Article
Reply to letter to the editor.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12831
By:
- Dangtakot, Rungtiwa;
- Intuyod, Kitti;
- Chamgramol, Yaovalux;
- Pairojkul, Chawalit;
- Pinlaor, Somchai;
- Jantawong, Chanakan;
- Pongking, Thatsanapong;
- Haonon, Ornuma;
- Ma, Ning;
- Pinlaor, Porntip
Publication type:
Article
Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections—Exploratory study.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12830
By:
- Gunaratne, Anoja W;
- Hamblin, Harrison;
- Clancy, Annabel;
- Magat, Aleja Jane Marie C;
- Dawson, Marie Vic M;
- Tu, Jeffrey;
- Borody, Thomas J
Publication type:
Article
IL‐9 contributes to the host immune response against Helicobacterpylori and helps limit infection in a Mouse Model.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12827
By:
- He, Yafei;
- Ning, Jie;
- Li, Bin;
- Guo, Hong;
- Hao, Ningbo;
- Wu, Chao
Publication type:
Article
Issue Information.
Published in:
Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12711
Publication type:
Article